Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Nivolumab 37pembrolizumab 30cabozantinib 27Specimen Handling 25Magnetic Resonance Spectroscopy 22Ipilimumab 20lenvatinib 16Axitinib 15belzutifan 13CTLA-4 Antigen 10Sunitinib 9Biopsy 9Radiosurgery 8atezolizumab 7Immunoglobulin G 5toripalimab 4fludarabine 4avelumab 4aldesleukin 4Everolimus 4Disulfides 4Cyclophosphamide 4zimberelimab 3tivozanib 3spartalizumab 3pazopanib 3palbociclib 3durvalumab 3cemiplimab 3X-Rays 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Tyrosine Kinase Inhibitors × 90 days × Clear all
NCT04777994 2026-06-04

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Calico Life Sciences LLC

Phase 1 Recruiting
248 enrolled
GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡